Publication | Closed Access

The absolute lymphocyte count can predict the overall survival of patients with non-small cell lung cancer on nivolumab: a clinical study

Overall SurvivalMedicineClinical StudyImmunologyPathologyImmune Checkpoint InhibitorBronchial NeoplasmCancer TreatmentOncologyRadiation OncologyLung CancerAbsolute Lymphocyte Count